Skip to Content
Home > Detail
<< Back to Results
This is a study to investigate the potential clinical benefit of G1T28 in protecting the bone marrow and preserving the immune system when administered prior to topotecan in patients previously treated for extensive-stage SCLC.
Kenneth A. Kuenzli II, RN864email@example.com
Thank you for your feedback!
Get the latest news on the health topics that matter most to you.
© 2018 Spartanburg Regional Healthcare System. All Rights Reserved.